Since the WHO has launched "international public health emergencies" in the past several times, the mechanisms for ensuring response, international humanitarian assistance, and assisting low- and middle-income countries with weak health systems are mostly the responsibility of high-income countries that have been developed. Therefore, the vaccine has been successfully developed. Afterwards, what is more important is the discussion of the ethical issues involved. In addition to facing the ownership of patents to ensure use,
How to deal whatsapp database with appropriate priorities and resource allocation issues, and how to ensure sufficient supply, also consider the economic ability of countries to purchase, these are the challenges. From vaccine research and development to international rescue, there is "vaccine politics" behind it. Judging from the recent publicity by the US and China in the news media, it is clear that both countries want to play the role of "savior" in this global epidemic. Where is the role of "Taiwan can help" on Taiwan's return to the WHO? Taiwan's outstanding performance in this wave of COVID-19 has undoubtedly provided the world with a successful
Example of the third line in the two extremes of pluralistic democracy and authoritarian social systems. In the "Taiwan Model", trust and transparency have become the keys . (left) and AIT Director Brent Christensen (right) put a "Taiwan can help" sticker on a cardboard box containing Taiwan's aid to the United States. Under the framework of "Taiwan can help", in addition to mask diplomacy, Taiwan has also made outstanding achievements in testing reagents and drug treatment technologies. Under the global commitment to treatment and vaccine development, Taiwan can use its local pharmaceutical farms that have fully complied with international standards (PIC/SGMP), and continue Taiwan's value in the supply of raw materials.